MicrofluidX makes key collaboration for microfluidics platform

CPI, MicrofluidX and the Cell and Gene Therapy Catapult have collaborated to develop bioprocessing technology for the rapid scale-up of cell and gene therapies

picture of

Breaking News

Solentim launches workflow for single stem cell cloning

The company aims to create, isolate and characterise the highest value cells for biological medicine development

Sartorius becomes DFKI shareholder

The Göttingen based life science group and DFKI have previously been working together in a joint research laboratory

Europital launches as a science-driven full service CRO

Expanded CRO services to support biotechs and mid-sized pharma companies across trials in more than 40 countries

Royal Society of Chemistry calls for R&D investment

The UK has fallen behind cohort nations in R&D investment, hampering efforts to boost productivity – with the impact ...

Scenic Biotech enters into genetic modifier collaboration with Genentech

Multi-year strategic collaboration in target discovery and therapeutic development based on Scenic Biotech’s disease ...

DCprime and Glycotope to advance cancer vaccination and therapeutic antibody platforms

DCprime, the front-runner in the field of relapse vaccines, and Glycotope GmbH, a clinical-stage oncology/immuno- ...

Delivering success for inhaled drug development programmes

No two inhaled drug development programmes will have exactly the same characteristics or drivers; so, to ensure the ...

Thermo Fisher collaborates with AstraZeneca and academics

The collaborations are part of Thermo Fisher's development of solutions for unmet needs in clinical biomarker discovery

Paradigm4 launches app for large-scale data analysis

The app enables users to assess biological hypotheses for target evaluation, disease progression, and precision medicine

Derisking and accelerating oral peptide delivery via computational drug development tools

The drug development pipeline increasingly comprises complex molecules, both large and small, that exhibit low ...

Accelerating vaccine development with AI

Despite the tremendous advances in medical science in recent decades, there is still so much about the human body that ...

Optimising gene therapy for now and the future

With multiple gene therapies currently approved for use in the US, dozens in pivotal trials and hundreds more in ...

Asymchem and Snapdragon enter global partnership

The investment partnership has provided funding for Snapdragon to complete its expansion plan to build cGMP drug ...

University of Oxford resumes vaccine trial

In large trials such as this, the researchers have said, it's expected that some participants will become unwell